Jones Jeffrey Alan bought CGEM
February 22, 2024 · Form 4 insider transaction
Jones Jeffrey Alan bought 125,000 shares of Cullinan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderJones Jeffrey Alan
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 22, 2024
Filing dateFebruary 23, 2024
Shares owned after125,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.